FDAsafety guidance66% confidence
FDA TA — ANDA212336
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Dr. Reddy's Labs; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA212336. Sponsor: DR REDDYS LABS LTD. Submission status: TA. Submission type: ORIG. Review priority: STANDARD.
Supporting Context
- Therapeutic area
- Smoking Cessation · Nicotine Replacement Therapy
- Sub-indication
- General
Related signal: FDA Grants AP Status for Nicotine Polacrilex by Dr. Reddy's Labs